Jump to the main content block
 

蘇奕彰 教授/博士 (Prof./Dr. Su, Yi-Chang)

Prof./Dr. Su, Yi-Chang
蘇奕彰 教授/醫學博士 (Prof. Yi-Chang Su, MD., PhD)
Position: Director
Tel.:02-2820-1999 ext 3101
Current Position:
1. Director, National Research Institute of Chinese Medicine (NRICM), Ministry of Health and Welfare (2020/Feb~)
2. President, Chinese Medical Advancement Foundation (CMAF) (2018/Jan~)
 
Education:
Doctor of Medicine, Graduate Institute of Chinese Medicine, China Medical University
Master of Medicine, Graduate Institute of Chinese Medicine, China Medical University
Bachelor of Medicine, Department of Chinese Medicine, China Medical University
 
Major Professional Experience
1. President, Taiwan Association for the Education of Chinese Medicine (TAECM)(2017~2022)
2. Professor, School of Chinese Medicine, China Medical University (2009/08~2021/07)
3. Chairman, Taiwan Association of Traditional Chinese Medical Literature and History (2017-2020)
4. Chairman, Taiwan Society for Pathology of Chinese Medicine(2010-2016)
5. Chairman, Taiwan Society for Health Promotion (2010-2013)
6. Chairman, School of Chinese Medicine, China Medical University (2009-2012, 2000-2003)
7. Director, Graduate Institute of Chinese Medical Science, China Medical University(2008-2009)
8. Curator, Lifu Museum of Chinese Medicine, China Medical University(2003-2008)
 
Specialty:
Chinese Medical Body Constitution, Chinese Medical Pathology, Chinese Medical Health Promotion , Clinical Research of Chinese Medicine Integrated with Western Medicine, Chinese Medicine Classics and Literature Research, Structure and Curriculum Design of Chinese Medicine Education 
 

Published Papers:

  NCBI PubMed : Yi-Chang Su (Please click!!)

  1. Ho ST, Tsai YN, Su YC. The development and application of NRICM101 and NRICM102 for the treatment of COVID-19. J Formos Med Assoc. online 26 April 2023. doi: 10.1016/j.jfma.2023.04.015.
  2. Lin JG, Huang GJ, Su YC. Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19. J Biomed Sci. 2023 May 3;30(1):30. doi: 10.1186/s12929-023-00923-5.
  3. Lee CH, Tsai CI, Su YC, Lin SY, Lee IT, Li TC. Traditional Chinese medicine body constitution predicts new-onset diabetic albuminuria in patients with type 2 diabetes: Taichung diabetic body constitution prospective cohort study. Medicine (Baltimore). 2022 Dec 16;101(50):e32342. doi: 10.1097/MD.0000000000032342.
  4. Chen CM, Tsai YN, Chen CH, Tseng YH, Jui-Shan Lin S, Su YC. Levonorgestrel intrauterine devices improve body constitution deviations in the perspective of traditional Chinese medicine and quality of life in patients with chronic pelvic pain and heavy menstrual bleeding. Taiwan J Obstet Gynecol. 2022 Nov;61(6):989-994. doi: 10.1016/j.tjog.2021.10.012.
  5. Tseng YH, Lin SJ, Lee MY, Su YC. Treating COVID-19 with NRICM101 and NRICM102 - Author's reply 3. Pharmacol Res. 2022 Nov;185:106445. doi: 10.1016/j.phrs.2022.106445. Epub 2022 Sep 9.
  6. Lee MY, Tseng YH, Lin SJ, Su YC. Treating COVID-19 with NRICM101 and NRICM102 - Author's reply 2. Pharmacol Res. 2022 Nov;185:106446. doi: 10.1016/j.phrs.2022.106446. Epub 2022 Sep 9.
  7. Lin SJ, Lee MY, Tseng YH, Su YC. Treating COVID-19 with NRICM101 and NRICM102 - Author's reply. Pharmacol Res. 2022 Nov;185:106438. doi: 10.1016/j.phrs.2022.106438. Epub 2022 Sep 9.
  8. Su YC, Huang GJ, Lin JG. Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101). Front Pharmacol. 2022 Oct 5;13:928106. doi: 10.3389/fphar.2022.928106. eCollection 2022.
  9. Wei WC, Liaw CC, Tsai KC, Chiou CT, Tseng YH, Chiou WF, Lin YC, Tsai CI, Lin CS, Lin CS, Liou KT, Yu IS, Shen YC, Su YC. Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis. Pharmacol Res. 2022 Oct;184:106424. doi: 10.1016/j.phrs.2022.106424. Epub 2022 Sep 5.
  10. Tseng YH, Lin SJ, Hou SM, Wang CH, Cheng SP, Tseng KY, Lee MY, Lee SM, Huang YC, Lin CJ, Lin CK, Tsai TL, Lin CS, Cheng MH, Fong TS, Tsai CI, Lu YW, Lin JC, Huang YW, Hsu WC, Kuo HH, Wang LH, Liaw CC, Wei WC, Tsai KC, Shen YC, Chiou WF, Lin JG, Su YC. Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis. Pharmacol Res. 2022 Oct;184:106412. doi: 10.1016/j.phrs.2022.106412. Epub 2022 Aug 23.
  11. Lue HC, Su YC, Lin SJ, Huang YC, Chang YH, Lin IH, Yang SP. Taipei consensus on integrative traditional Chinese and Western Medicine. J Formos Med Assoc. 2021 Jan;120(1 Pt 1):34-47. doi: 10.1016/j.jfma.2020.02.005. Epub 2020 Mar 6.
  12. Tsai KC, Huang YC, Liaw CC, Tsai CI, Chiou CT, Lin CJ, Wei WC, Lin SJ, Tseng YH, Yeh KM, Lin YL, Jan JT, Liang JJ, Liao CC, Chiou WF, Kuo YH, Lee SM, Lee MY, Su YC. A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study. Biomed Pharmacother. 2021 Jan;133:111037. doi: 10.1016/j.biopha.2020.111037. Epub 2020 Nov 19.
  13. Kung YY, Kuo TBJ, Lai CT, Shen YC, Su YC, Yang CCH. Disclosure of suboptimal health status through traditional Chinese medicine-based body constitution and pulse patterns. Complement Ther Med. 2021 Jan;56:102607. doi: 10.1016/j.ctim.2020.102607. Epub 2020 Nov 19.
  14. Tsai YN, Chang YH, Huang YC, Jui-Shan Lin S, Lee SM, Cheng YY, Su YC. The use of time-domain analysis on the choice of measurement location for pulse diagnosis research: A pilot study. J Chin Med Assoc. 2019 Jan;82(1):78-85. doi: 10.1016/j.jcma.2018.07.002.
  15. 黃信麒、蔡忠志、蘇奕彰,〈日治時期的臺灣藥用植物研究回顧——以蕨類門為例〉,《中醫藥雜誌》,2019 Dec,30(2):1-26。
  16. Huang YC, Lin CJ, Cheng SM, Lin CK, Lin SJ, Su YC. Using Chinese Body Constitution Concepts and Measurable Variables for Assessing Risk of Coronary Artery Disease. Evid Based Complement Alternat Med. 2019 Sep 16;2019:8218013.
  17. Huang YC, Chang YH, Cheng SM, Lin SJ, Lin CJ, Su YC. Applying Pulse Spectrum Analysis to Facilitate the Diagnosis of Coronary Artery Disease. Evid Based Complement Alternat Med. 2019 Jun 3;2019:2709486.
  18. Schmied PA, Lin JS, Ruffieux C, Barras V, Su YC. How does Clinical Setting Affect Acupuncture Practice in Taiwan: a comparison between Chinese Medicine Physicians Practicing in General Hospitals and in Chinese Medicine hospitals and Clinics. J Chin Med. 2019 Jun;30(1):99-122.
  19. Schmied PA, Su YC. Innovation and adaptation in contemporary Taiwanese acupuncture: changes in needling insertion technique as an example. J Chin Med. 2018 Dec;29(2):113-127.
  20. Tsai YN, Chang YH, Huang YC, Jui-Shan Lin S, Lee SM, Cheng YY, Su YC. The use of time-domain analysis on the choice of measurement location for pulse diagnosis research: A pilot study. J Chin Med Assoc. 2018 Sep 6. pii: S1726-4901(18)30208-9.
  21. Tsai YN, Huang YC, Lin SJ, Lee SM, Cheng YY, Chang YH, Su YC. Different Harmonic Characteristics Were Found at Each Location on TCM Radial Pulse Diagnosis by Spectrum Analysis. Evid Based Complement Alternat Med. 2018 Jul 5;2018:9018271.
  22. Lin SA, Chu PY, Chen LL, Su YC, Wang SM. The prevalence rate of deviations in body constitutions and related factors in follow-up stage breast cancer patients-A nationwide study. Complement Ther Med. 2017 Jun;32:49-55.
  23. Fleischer T, Su YC, Lin SJ. How do government regulations influence the ability to practice Chinese herbal medicine in western countries. J Ethnopharmacol. 2017 Jan 20;196:104-109.
  24. Lee CH, Li TC, Tsai CI, Lin SY, Lee IT, Lee HJ, Wu YC, Su YC. Association between Albuminuria and Different Body Constitution in Type 2 Diabetes Patients: Taichung Diabetic Body Constitution Study. Evid Based Complement Alternat Med. 2015;2015:603048.
  25. Chiang PJ, Li TC, Chang CH, Chen LL, Lin JD, Su YC. SEED: the six excesses (Liu Yin) evaluation and diagnosis scale. Chin Med. 2015 Oct 27;10:30.
  26. Shih CC, Liao CC, Sun MF, Su YC, Wen CP, Morisky DE, Sung FC, Hsu CY, Lin JG. A Retrospective Cohort Study Comparing Stroke Recurrence Rate in Ischemic Stroke Patients With and Without Acupuncture Treatment. Medicine (Baltimore). 2015 Sep;94(39):e1572.
  27. Lee CH, Li TC, Tsai CI, Lin SY, Lee IT, Lee HJ, Wu YC, Su YC. Yang Deficiency Body Constitution Acts as a Predictor of Diabetic Retinopathy in Patients with Type 2 Diabetes: Taichung Diabetic Body Constitution Study. Evid Based Complement Alternat Med. 2015;2015:940898.
  28. Su CC, Liu SH, Lee KI, Huang KT, Lu TH, Fang KM, Wu CC, Yen CC, Lai CH, Su YC, Huang CF. Cantharidin Induces Apoptosis Through the Calcium/PKC-Regulated Endoplasmic Reticulum Stress Pathway in Human Bladder Cancer Cells. Am J Chin Med. 2015;43(3):581-600.
  29. Liu SH, Lu TH, Su CC, Lay IS, Lin HY, Fang KM, Ho TJ, Chen KL, Su YC, Chiang WC, Chen YW. Lotus leaf (Nelumbo nucifera) and its active constituents prevent inflammatory responses in macrophages via JNK/NF-κB signaling pathway. Am J Chin Med. 2014;42(4):869-89.
  30. Tsai CI, Su YC, Lin SY, Lee IT, Lee CH, Li TC. Reduced health-related quality of life in body constitutions of yin-xu, and yang-xu, stasis in patients with type 2 diabetes: taichung diabetic body constitution study. Evid Based Complement Alternat Med. 2014;2014:309403.
  31. Huang KC, Chen CC, Su YC, Lin JS, Chang CT, Wang TY, Chen RH, Tsai FJ. The Relationship between Stasis-Stagnation Constitution and Peripheral Arterial Disease in Patients with Type 2 Diabetes. Evid Based Complement Alternat Med. 2014;2014:903798.
  32. Lin SJ, Cheng YY, Chang CH, Lee CH, Huang YC, Su YC. Traditional chinese medicine diagnosis "yang-xu zheng": significant prognostic predictor for patients with severe sepsis and septic shock. Evid Based Complement Alternat Med. 2013;2013:759748.
  33. Tsai CI, Li TC, Chang MH, Lin SY, Lee IT, Lee CH, Wang TY, Su YC. Chinese Medicinal Formula (MHGWT) for Relieving Diabetic Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med. 2013;2013:767498.
  34. Lin CJ, Su YC, Lee CH, Li TC, Chen YA, Lin SJ. Bai-hu-tang, ancient chinese medicine formula, may provide a new complementary treatment option for sepsis. Evid Based Complement Alternat Med. 2013;2013:193084.
  35. Chang KC, Hsu CC, Liu SH, Su CC, Yen CC, Lee MJ, Chen KL, Ho TJ, Hung DZ, Wu CC, Lu TH, Su YC, Chen YW, Huang CF. Cadmium induces apoptosis in pancreatic β-cells through a mitochondria-dependent pathway: the role of oxidative stress-mediated c-Jun N-terminal kinase activation. PLoS One. 2013;8(2):e54374.
  36. Chen CH, Chen SJ, Su CC, Yen CC, Tseng TJ, Jinn TR, Tang FC, Chen KL, Su YC, Lee kI, Hung DZ, Huang CF. Chloroacetic acid induced neuronal cells death through oxidative stress-mediated p38-MAPK activation pathway regulated mitochondria-dependent apoptotic signals. Toxicology. 2013 Jan 7;303:72-82.
  37. Lin JD, Lin JS, Chen LL, Chang CH, Huang YC, Su YC. BCQs: A Body Constitution Questionnaire to assess Stasis in traditional Chinese medicine. Eur J Integr Med. 2012 Dec;4(4):e379-e391.
  38. Lin JS, Chen LL, Lin JD, Chang CH, Huang CH, Mayer PK, Su YC. BCQ-: A Body Constitution Questionnaire to assess Yin-Xu. Part II: evaluation of reliability and validity. Forsch Komplementmed. 2012;19(6):285-92.
  39. Lin JD, Chen LL, Lin JS, Chang CH, Huang YC, Su YC. BCQ-: a body constitution questionnaire to assess Yin-Xu. Part I: establishment of a provisional version through a Delphi process. Forsch Komplementmed. 2012;19(5):234-41.
  40. Chen KL, Liu SH, Su CC, Yen CC, Yang CY, Lee KI, Tang FC, Chen YW, Lu TH, Su YC, Huang CF. Mercuric compounds induce pancreatic islets dysfunction and apoptosis in vivo. Int J Mol Sci. 2012 Sep 26;13(10):12349-66.
  41. Shih CC, Liao CC, Su YC, Tsai CC, Lin JG. Gender differences in traditional Chinese medicine use among adults in Taiwan. PLoS One. 2012;7(4):e32540.
  42. Liang KL, Jiang RS, Lee CL, Chiang PJ, Lin JS, Su YC. Traditional Chinese Medicine ZHENG Identification Provides a Novel Stratification Approach in Patients with Allergic Rhinitis. Evid Based Complement Alternat Med. 2012;2012:480715.
  43. Wu CC, Yen CC, Lee kI, Su CC, Tang FC, Chen KL, Su YC, Chen YW. Involvement of oxidative stress-induced ERK/JNK activation in the Cu(2+)/pyrrolidine dithiocarbamate complex-triggered mitochondria-regulated apoptosis in pancreatic β-cells. Toxicol Lett. 2012 Feb 5;208(3):275-85.
  44. Huang CH, Lin JS, Li TC, Lee SC, Wang HP, Lue HC, Su YC. Comparison of a Chinese Herbal Medicine (CCH1) and Lactulose as First-Line Treatment of Constipation in Long-Term Care: A Randomized, Double-Blind, Double-Dummy, and Placebo-Controlled Trial. Evid Based Complement Alternat Med. 2012;2012:923190.
  45. Fong YC, Lin CY, Su YC, Chen WC, Tsai FJ, Tsai CH, Huang CY, Tang CH. CCN6 enhances ICAM-1 expression and cell motility in human chondrosarcoma cells. J Cell Physiol. 2012 Jan;227(1):223-32.
  46. Wang HL, Lee TC, Kuo SH, Chou FH, Chen LL, Su YC, Chen LM. Relationships among Constitution, Stress, and Discomfort in the First Trimester. Evid Based Complement Alternat Med. 2012;2012:486757.
  47. Wu CM, Li TM, Hsu SF, Su YC, Kao ST, Fong YC, Tang CH. IGF-I enhances α5β1 integrin expression and cell motility in human chondrosarcoma cells. J Cell Physiol. 2011 Dec;226(12):3270-7.
  48. 陳名婷、林睿珊、蘇奕彰,〈宋代校正醫書局之編修人員考〉,《台灣中醫醫學雜誌》,2011 Dec,10(4):27-34。
  49. Wu HC, Yang CY, Hung DZ, Su CC, Chen KL, Yen CC, Ho TJ, Su YC, Huang CF, Chen CH, Tsai LM, Chen YW. Nickel(II) induced JNK activation-regulated mitochondria-dependent apoptotic pathway leading to cultured rat pancreatic β-cell death. Toxicology. 2011 Nov 18;289(2-3):103-11.
  50. Li TM, Lin TY, Hsu SF, Wu CM, Su YC, Kao ST, Chang CS, Fong YC, Tang CH. The novel benzimidazole derivative, MPTB, induces cell apoptosis in human chondrosarcoma cells. Mol Carcinog. 2011 Oct;50(10):791-803.
  51. 林政憲、蘇奕彰,〈匯通式的轉折—論章太炎醫學思想的轉變〉,《台灣中醫醫學雜誌》,2011 Sep,10(3):29-38。
  52. 胡展榕、林政憲、黃怡超、蘇奕彰,〈國立中國醫藥研究所之籌設探源〉,《台灣中醫醫學雜誌》,2011 Sep,10(3):47-58。
  53. Lu TH, Hsieh SY, Yen CC, Wu HC, Chen KL, Hung DZ, Chen CH, Wu CC, Su YC, Chen YW, Liu SH, Huang CF. Involvement of oxidative stress-mediated ERK1/2 and p38 activation regulated mitochondria-dependent apoptotic signals in methylmercury-induced neuronal cell injury. Toxicol Lett. 2011 Jul 4;204(1):71-80.
  54. Huang CH, Su YC, Li TC, Lee SC, Lin JS, Chiu TY, Lue HC. Treatment of constipation in long-term care with Chinese herbal formula: a randomized, double-blind placebo-controlled trial. J Altern Complement Med. 2011 Jul;17(7):639-46.
  55. Yen CC, Ho TJ, Wu CC, Chang CF, Su CC, Chen YW, Jinn TR, Lu TH, Cheng PW, Su YC, Liu SH, Huang CF. Inorganic arsenic causes cell apoptosis in mouse cerebrum through an oxidative stress-regulated signaling pathway. Arch Toxicol. 2011 Jun;85(6):565-75.
  56. 蔡運寧、蘇奕彰、李采娟、張鈺鑫,〈中指同身寸取穴定位與性別及身體質量指數之相關研究〉,《台灣中醫醫學雜誌》,2011 Jun,10(2):49-55。
  57. 陳名婷、林睿珊、蘇奕彰,〈宋代官修醫書考〉,《台灣中醫醫學雜誌》,2011 Jun,10(2):25-37。
  58. 林政憲、蘇奕彰,〈余雲岫之中醫學術研究述評〉,《台灣中醫醫學雜誌》,2011 Mar,10(1):37-43。
  59. 游文仁、蘇奕彰,〈台北國圖館藏《影北宋本傷寒論》作偽者考辨〉,《中華醫史雜誌》,2011 Jan,2011(1):31-39。

 

Click Num: